VERTEX PHARMACEUTICALS INC / MA Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Vertex Pharmaceuticals Inc / Ma Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.4B, a 350% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.4B +$1.09B +350% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $570M +$246M +75.7% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $313M -$23.4M -6.96% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $294M -$53.8M -15.5% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $311M -$32.2M -9.4% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $324M +$6M +1.89% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $336M +$7.3M +2.22% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $347M +$17.1M +5.18% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $343M +$30.4M +9.72% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $318M +$1.43M +0.45% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $329M +$6.68M +2.07% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $330M +$4.7M +1.44% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $312M +$55.5M +21.6% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $317M Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $322M Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $326M +$237M +269% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $257M +$196M +321% Sep 30, 2020 10-Q 2020-10-30
Q4 2019 $88.2M +$26.5M +43% Dec 31, 2019 10-K 2021-02-11
Q3 2019 $60.9M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $58M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $60.6M Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $61.7M Jan 1, 2019 10-Q 2019-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.